Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (20) , 3861-3866
- https://doi.org/10.1016/0006-2952(88)90067-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Hepatic reactions associated with ketoconazole in the United Kingdom.BMJ, 1987
- Ketoconazole and Other Imidazole Derivatives as Inhibitors of SteroidogenesisEndocrine Reviews, 1986
- Ketoconazole hepatotoxicity: An in vitro modelBiochemical Pharmacology, 1986
- Cytochrome p‐450: Target for itraconazoleDrug Development Research, 1986
- Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agentsBiochemical Pharmacology, 1986
- Imidazole antimycotics: Inhibitors of steroid aromataseBiochemical Pharmacology, 1985
- The interaction of representative members from two classes of antimycotics—the azoles and the allylamines—with cytochromes P-450 in steroidogenic tissues and liverXenobiotica, 1985
- Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*Journal of Clinical Endocrinology & Metabolism, 1983
- Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.Journal of Clinical Investigation, 1983
- THE EFFECT OF KETOCONAZOLE ON STEROIDOGENESIS IN CULTURED MOUSE ADRENAL CORTEX TUMOR CELLS*Endocrinology, 1983